(Q45962212)

18 December 2017

title

Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats. (English)

1 reference

18 December 2017

6

Jan Malý

1 reference

18 December 2017

author name string

Libor Kopkan

1

1 reference

18 December 2017

Zuzana Husková

2

1 reference

18 December 2017

Zdenka Vanourková

3

1 reference

18 December 2017

Monika Thumová

4

1 reference

18 December 2017

Petra Skaroupková

5

1 reference

18 December 2017

Herbert J Kramer

7

1 reference

18 December 2017

Pavel Dvorák

8

1 reference

18 December 2017

Ludek Cervenka

9

1 reference

18 December 2017

publication date

16 June 2009

1 reference

18 December 2017

published in

Vascular Pharmacology

1 reference

18 December 2017

volume

51

1 reference

18 December 2017

issue

2-3

1 reference

18 December 2017

page(s)

175-181

1 reference

18 December 2017

Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Angiotensin II chronic infusion induces B1 receptor expression in aorta of rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Pivotal role of angiotensin II receptor subtype 1A in the development of two-kidney, one-clip hypertension: study in angiotensin II receptor subtype 1A knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

NO-independent mechanism mediates tempol-induced renal vasodilation in SHR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Role of oxidative stress in the sex differences in blood pressure in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

NADPH oxidases and angiotensin II receptor signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Angiotensin II formation in the kidney and nephrosclerosis in Ren-2 hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Effects of anesthesia on plasma and kidney ANG II levels in normotensive and ANG II-dependent hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Effects of dietary salt load and salt depletion on the course of hypertension and angiotensin II levels in male and female heterozygous Ren-2 transgenic rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

A mouse model of angiotensin II slow pressor response: role of oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

The role of intrarenal angiotensin II in the development of hypertension in Ren-2 transgenic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Superoxide and its interaction with nitric oxide modulates renal function in prehypertensive Ren-2 transgenic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Superoxide contributes to development of salt sensitivity and hypertension induced by nitric oxide deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Role of superoxide in modulating the renal effects of angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Increased renal medullary H2O2 leads to hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Oxidative stress and antioxidant treatment in hypertension and the associated renal damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Systemic and Regional Hemodynamic Responses to Tempol in Angiotensin II-Infused Hypertensive Rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Antioxidants block angiotensin II-induced increases in blood pressure and endothelin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

NAD(P)H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Oxidant stress and blood pressure responses to angiotensin II administration in rats fed varying salt diets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Early-onset endothelin receptor blockade in hypertensive heterozygous Ren-2 rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

AT1 receptor antisense therapy transiently lowers blood pressure in Ren-2 transgenic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Long-term prevention of hypertension and end-organ damage in Ren-2 transgenic rats is achieved only with persistent but not transient AT1 receptor blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

AT1 receptor blockade is superior to conventional triple therapy in protecting against end-organ damage in Cyp1a1-Ren-2 transgenic rats with inducible hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Angiotensin II-dependent superoxide: effects on hypertension and vascular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Antihypertensive response to prolonged tempol in the spontaneously hypertensive rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Roles of oxidative stress and AT1 receptors in renal hemodynamics and oxygenation in the postclipped 2K,1C kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Chemistry and antihypertensive effects of tempol and other nitroxides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Arterial pressure response to the antioxidant tempol and ETB receptor blockade in rats on a high-salt diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Normalisation of blood pressure in hypertensive TGR(mREN2)27 rats by amlodipine vs. enalapril: effects on cardiac hypertrophy and signal transduction pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.06.001

10.1016/J.VPH.2009.06.001

7 January 2021

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017